Corcept Therapeutics | CORT - Ordinary Share Capital


Corcept Therapeutics reported $107.33M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 169.18M 470K Dec/2025
Alaunos Therapeutics USD 2.38M 172K Mar/2026
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Ardelyx USD 244.35M 1.38M Dec/2025
Assertio Holdings USD 9K 0 Dec/2023
Aurora Cannabis CAD 56.71M 134.13K Dec/2025
BioMarin Pharmaceutical USD 193.27M 969K Mar/2026
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Canopy Growth CAD 368.28M 35.9M Dec/2025
Corcept Therapeutics USD 107.33M 1.36M Mar/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
J&J USD 2.41B 1.74M Dec/2025
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Lexicon Pharmaceuticals USD 363.47M 67K Dec/2025
Merck USD 2.47B 12.72M Dec/2025
Nektar Therapeutics USD 20.38M 20.36M Dec/2025
Novartis USD 1.91B 60K Mar/2026
Novartis USD 1.91B 10.64M Dec/2025
Omeros USD 611K 17K Dec/2023
Pacira USD 39.31M 1.81M Mar/2026
Pfizer USD 5.7B 13M Mar/2026
Supernus Pharmaceuticals USD 58.04M 582K Mar/2026
TG Therapeutics USD 155.31M 95K Dec/2025